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A positive effect of breastfeeding on lung function has been demonstrated in cohorts of 3 
children with asthma or risk for asthma. We assessed the impact of breastfeeding on lung 4 
function and symptoms at the age of six years in an unselected, healthy birth cohort.  5 
Methods  6 
We prospectively studied healthy term infants from the Bern-Basel Infant Lung Development 7 
(BILD) cohort from birth up to 6 years. Any breastfeeding was assessed by weekly phone 8 
calls during the first year of life. Risk factors (e.g. smoking exposure, parental history of 9 
allergic conditions, and education) were obtained using standardized questionnaires. The 10 
primary outcomes were lung function parameters measured at 6 years of age by spirometry 11 
(FEV1), body plethysmography (FRCpleth, TLCpleth, Reff) and FeNO. Secondary outcomes 12 
included ever wheeze (between birth and 6 years), wheeze in the past 12 months, asthma, 13 
presence of allergic conditions, atopic dermatitis, rhinitis, and positive skin prick test at the 14 
age of 6 years. 15 
Results 16 
In 377 children the mean breastfeeding duration was 36 weeks (SD 14.4). We found no 17 
association of breastfeeding duration with obstructive or restrictive lung function and FeNO. 18 
After adjustment for confounders we found no associations of breastfeeding duration with 19 
respiratory symptoms or presence of allergic conditions.  20 
Conclusion 21 
This study found no evidence of association between breastfeeding and comprehensive lung 22 
function in unselected healthy children with long-term breastfeeding. Our findings do not 23 
support the hypothesis that the duration of breastfeeding has a direct impact on lung function 24 





Breastfeeding has a variety of beneficial effects for children1. Many studies have provided clear 2 
evidence that breastfeeding reduced the risk of respiratory morbidity in early life.2-7 The effect 3 
of breastfeeding on lung function and atopic diseases including asthma in childhood is less 4 
consistent. A meta-analysis by Dogaru et al. showed a protective association between 5 
breastfeeding and asthma with the strongest effect in the first two years of life,8,9 whereas 6 
another meta-analysis reported a decreased risk of asthma in children aged 5-18 years, but in 7 
children from studies with insufficient adjustment for confounders. Furthermore the effect of 8 
breastfeeding on other allergic disease is still conflicting. 9-11   9 
There is some evidence that breastfeeding could improve school-aged lung function, but the 10 
positive association was seen predominantly in studies with a relatively high number of children 11 
with atopic/asthmatic mothers12-16 or from subgroups of children of asthmatic mothers,17 12 
suggesting that the relationship between breastfeeding and lung function might be mediated by 13 
atopic disease. Indeed, the ALSPAC cohort of healthy unselected children, found no effect of 14 
breastfeeding on bronchial responsiveness.18 Few studies are available linking breastfeeding 15 
with fractional exhaled nitric oxide (FeNO)19 or more comprehensive lung function. Taken 16 
together, results seem to be heterogeneous and influenced by risk factors, categorization and 17 
duration of breastfeeding.  18 
From a mechanistic point of view, it is unclear whether the protective effect of breastfeeding is 19 
related to inflammatory mechanisms in asthma and subsequent remodeling and impaired lung 20 
growth or whether breastfeeding directly affects lung functional development. To address the 21 
latter hypothesis, we aimed to assess the effect of breastfeeding duration on lung function at 6 22 
years of age in a prospective unselected birth cohort study of primarily healthy children with 23 
an appropriate adjustment for confounders and comprehensive lung function outcomes such as 24 




and allergic diseases at the age of 6 years, such as ever wheeze, wheeze in the past 12 months, 1 
presence of allergic conditions, atopic dermatitis, rhinitis, and positive skin prick test.  2 
 3 
Methods 4 
Study design and subjects 5 
Data was obtained from the ongoing prospective Basel-Bern Infant Lung Development (BILD) 6 
birth cohort, collected since 1999 in Switzerland. Pregnant women were recruited antenatally 7 
in four maternity hospitals and practices of gynecologists in the region of Bern. Unselected 8 
healthy children were followed up at 6 years after enrollment.20 Exclusion criteria for the study 9 
were preterm delivery (<37 weeks) and significant perinatal disease, including respiratory 10 
distress and known major birth defects. Assessments were undertaken at ages 1 and 6 years. 11 
The assessment in the first year of life comprised clinical examination at the age 1 month in the 12 
study clinic, weekly phone interviews and information from perinatal records. At the age of 6 13 
years, parents were mailed a questionnaire with questions on allergy and respiratory symptoms 14 
as well as environmental exposure, and were offered a visit to the study clinic. During the 15 
follow-up visit the history of wheeze episodes between birth and age 6, including their 16 
frequency, severity and trigger factors were recorded by trained study physicians using 17 
standardized questionnaires. Children also underwent a lung function measurement and a skin 18 
prick test. This study focuses on the follow-up assessments conducted between August 2005 19 
and April 2018. The Ethics Committee of the Region of Bern approved the study and written 20 
consent was obtained at enrollment and again at follow-up. 21 
Exposure: breastfeeding 22 
During the 1st year of life mothers were asked weekly by telephone interview with a study 23 
nurse about their breastfeeding status until they completely stopped breastfeeding. Any 24 




Primary outcome: lung function at 6 years  1 
Spirometry and body plethysmography were performed at the age of 6 years using MasterLab 2 
setup (Jaeger, Wurzburg, Germany) according to current ERS/ATS guidelines.21 The primary 3 
spirometry outcome was FEV1 according to ERS/ATS criteria.22  4 
Body plethysmography measurements were done to assess the functional residual capacity 5 
(FRCpleth), the total lung capacity (TLCpleth) and the effective respiratory airway resistance 6 
(Reff). FRCpleth and TLCpleth were assessed according to European standards23 and Reff was 7 
determined as the mean of at least five separate specific resistance loops.24  Fractional exhaled 8 
nitric oxide (FeNO) was used as a measure of eosinophilic airway inflammation and measured 9 
online (CLD88sp FeNO analyser, ECO MEDICS, Duernten, Switzerland). Compliant to the 10 
ATS/ERS recommendations, the mean of two or three reproducible FeNO values has been 11 
reported.25  12 
Secondary outcome: clinical data  13 
Standardized questions on key clinical outcomes (e.g. wheeze, atopic dermatitis, and rhinitis) 14 
were adapted from the International Study on Asthma and Allergy in Childhood (ISAAC) 15 
questionnaire.26  16 
Ever wheeze was obtained from a physician-administered questionnaire and defined as 17 
present if the question “Has your child ever had wheezing or whistling at any time in the 18 
past?” was answered positively. Current wheeze was defined as present if the question “Has 19 
your child had wheezing or whistling in the past 12 months?” was answered positively.  20 
According to the GINA guidelines 2018,27 asthma was defined as present if there was 21 
cough/wheezing/ difficult or heavy breathing in the absence of an apparent respiratory 22 
infection in the last 12 months in combination with an asthma-medication (inhaled 23 
corticosteroids or ß-agonists) used in the last 12 months and/or a positive past history of 24 
allergic conditions (atopic dermatitis and/or rhinitis/rhinoconjunctivitis) and/or a positive 25 




Rhinitis/rhinoconjunctivitis was defined as parent-reported prolonged sneezing, runny or 1 
blocked nose accompanied by ocular itching and tearing without a common cold in the last 12 2 
months, according to international standards.28,29  3 
Based on modified Hanifin and Rajka criteria,30 atopic dermatitis at 6 years was defined as 4 
present if 3 of 4 major criteria were met: (1) pruritus in the last 12 months, (2) typical 5 
morphology and distribution, (3) chronic dermatitis, (4) personal or family history of atopy 6 
allergic conditions (asthma, rhinitis and/or atopic dermatitis). Infants were defined as having 7 
atopic dermatitis in the first year of life if they had at least one of the following occurrences in 8 
the first year of life: (1) pruritus or/and rashes (e.g redness, dryness and papules) with the 9 
distribution in at least 2 typical regions; (2) recurrent dermatitis/rashes within the first year of 10 
life; (3) doctor diagnosed atopic dermatitis or treatment with topical steroids. We excluded 11 
skin lesions caused by cradle cap and seborrhoeic dermatitis.  12 
Presence of allergic conditions was defined as the presence of asthma and/or  13 
rhinitis/rhinoconjunctivitis and/or atopic dermatitis.  14 
A skin prick (at 6 years) was defined as positive for at least one of the following measured 15 
allergens: dog dander, cat dander, dermatophagoides pteronyssinus, mixed tree pollens, mixed 16 
grass pollens, alternaria tenuis. The test was defined as positive if a weal diameter was bigger 17 
than the histamin in any of the tested allergens compared to a valid negative and a valid 18 
positive (histamine ≥ 3mm) control.31  19 
Risk factors 20 
Other risk factors included parental history of allergic conditions (defined as asthma, rhinitis 21 
or atopic dermatitis), mode of delivery (vaginal or cesarean), maternal educational level as a 22 
marker of socioeconomic status, older siblings, maternal smoking during pregnancy, and 23 




Statistical analysis 1 
All variables were examined in relation to their ranges, distributions, means, standard 2 
deviations, outliers and logical errors. For later analysis FeNO was log transformed. The 3 
relationship between breastfeeding and outcomes were tested for possible non-linearity. We 4 
found no evidence for the curvilinear relation of breastfeeding to lung function and clinical 5 
outcomes. In order to investigate the association of breastfeeding with pulmonary function 6 
measures, we first performed linear regression analysis with standard adjustments for age, 7 
sex, and height (baseline model). Second, we used linear regression analysis with additional 8 
adjustments for gestational length, parental history of allergic conditions, and maternal 9 
smoking during pregnancy (adjusted model). Estimates are presented as change or a percent 10 
change (for back-transformed outcomes) in the lung function parameters per week of any 11 
breastfeeding with their 95% confidence intervals (CIs). To exclude the possible effect 12 
mediation by respiratory infection in early life, we performed a sensitivity analysis with 13 
adjustment for number of weeks with respiratory symptoms accessed during the 1 year of life. 14 
We did not investigate the possible effect of modification by maternal asthma because of the 15 
low number of children with asthmatic mothers. 16 
The association of breastfeeding with secondary outcomes was assessed using, first, 17 
univariable logistic regression, and then after adjustment for sex, maternal smoking during 18 
pregnancy, parental history of allergic conditions, and maternal education. Ever wheeze was 19 
additionally adjusted for the presence of older siblings. Results are presented as odds ratios 20 
(ORs) with 95% CIs. 21 
All data processing and analyses were performed in STATA 15.0 (Stata Cooperation, college 22 
Station, TX) and R (Version 3.31)32. Significance was defined by a p-value less than 0.05 for 23 






Between 1999 and 2012, 458 children were enrolled in the BILD study. Among these, 377 3 
(82%) had a documented follow-up visit between 2005 and 2018. 8 (2%) children did not 4 
meet the inclusion criteria as described above, 73 (16%) we lost to follow-up.  The 5 
characteristics of included versus non-included children are shown in the Table S1. There 6 
was a significant difference between included and non-included children for maternal 7 
smoking during pregnancy and parental smoking during the first year of life, and the mean 8 
duration of breastfeeding was significantly shorter in the non-included than in the included 9 
children.  10 
32 (8%) participants did not show for the follow-up lung function test at 6 years, but sent the 11 
questionnaire back.  279 (74%) of 377 had available data on FeNO measurements. The 12 
quality control of lung function resulted in 204 children (54%) with spirometry and 263 13 
children (70%) with body plethysmography data (Figure S1). Table 1 shows the 14 
anthropometric data, potential risk factors, spirometry, FeNO and body 15 
plethysmography data for the whole study population.   16 
Breastfeeding prevalence 17 
Overall, 5 children (1%) were not breastfed at all, 78 (21%) were breastfed less than 6 18 
months. The mean (SD) duration of breastfeeding for those who received breastfeeding was 19 
36.5 (13.9) weeks. Duration of breastfeeding according to exposure characteristics at birth is 20 
shown in Table S2.  Maternal smoking during pregnancy was only significantly associated 21 
with shorter duration of breastfeeding. 22 
Association of breastfeeding with lung function and clinical symptoms 23 
Duration of breastfeeding was not associated with lung function (Table 2). There were no 24 




education or respiratory symptoms in the first year of life did not change the effect estimates 1 
(data not shown).  2 
In a univariable model we found significant evidence for a 2% reduction in presence of 3 
allergic conditions for each week of breastfeeding (Table 2). However, after control for 4 
confounders we found no evidence for association of breastfeeding with any of secondary 5 
clinical outcomes (Table 2).  6 
Discussion 7 
In this prospective cohort study of primarily healthy unselected children followed from birth 8 
until school age, we found no significant effect of breastfeeding duration on lung functional 9 
outcomes, if adjusted for known confounders. The physiological relevance of the findings was 10 
strengthened by the consistency across several functional outcomes at school age.  We found 11 
no evidence of airway obstruction, altered residual or end-expiratory volume nor restricted total 12 
lung capacity. With respect to secondary outcomes, we observed that a longer duration of 13 
breastfeeding was associated with a reduced risk of atopic dermatitis in girls. For every week 14 
mothers continued breastfeeding, the risk of having atopic dermatitis was reduced by 4%. There 15 
was no significant effect of breastfeeding duration on other clinical data such as asthma, ever 16 
wheeze, current wheeze, rhinitis or positive skin prick test. Sensitivity analysis of lung function 17 
outcomes excluding children who developed asthma during preschool age showed consistent 18 
results (Table S3). 19 
Primary outcomes. In contrast to asthma cohort studies,12,13,15,17 we found no effect of 20 
breastfeeding on lung function outcomes in unselected, primarily healthy children. Similarly 21 
we could not demonstrate an effect of breastfeeding on FeNO, a marker of eosinophilic 22 
inflammation in asthma, as suggested by others19. Studies investigating the effect of 23 
breastfeeding on lung function are heterogeneous with regards to age (mixed preschool and 24 




there is evidence that breastfeeding has the most consistent beneficial effect on FVC.33 1 
However, of the three cohort studies reporting on the effect of breastfeeding on FVC, two were 2 
based on the Isle of White cohort and one on The Tucson Children's Respiratory Study with 3 
enrolment periods from 1980 to 1984 and from 1989 to 1990, respectively.16,34 FVC is highly 4 
cooperation-dependent in preschoolers, strict quality control criteria in our cohort did not allow 5 
us to collect a high enough sample size (Table 1) to confirm data from the literature.  6 
Furthermore, in comparison to our primarily healthy cohort, these cohorts (ALSPAC, the Isle 7 
of White, and Tucson Children's Respiratory Study) are characterized by lower duration of 8 
breastfeeding and higher prevalence of asthmatic/atopic mothers and maternal smoking. In 9 
addition, depending on the enrolment period, changes in environmental factors, prevalence of 10 
respiratory infection and medical care may contribute to both changes in breastfeeding duration 11 
and lung functional growth. Our findings are, however, in line with the subgroup of healthy 12 
offspring of non-asthmatic mothers, and the ALSPAC and PROBIT studies, which did not find 13 
an effect of breastfeeding on lung function.18,35 Our findings are consistent with the hypothesis, 14 
that breastfeeding has no direct strong impact on lung functional development. Combining 15 
knowledge from other studies and our findings, we may speculate that the impact of 16 
breastfeeding on lung functional development may be a secondary effect mediated by 17 
susceptibility to early viral infections or chronic inflammatory processes at preschool age, such 18 
as described in asthma (Figure 1).  19 
Secondary outcomes. In contrast to studies reporting an association between breastfeeding and 20 
allergic disease, in our unselected, primarily healthy cohort we found no effect of breastfeeding 21 
on asthma and respiratory symptoms, nor on presence of allergic conditions. This may be 22 
related to the limited sample size, which would not allow us to assess small and probably 23 
clinically less relevant effects. Another reason for contrasting results is the low prevalence of 24 
children with asthma and wheeze in our cohort compared to many other cohorts.36,37 We have, 25 




studies it has been shown that breastfeeding protected children from atopic dermatitis.38,39 Other 1 
authors could not find a protective effect at any age, from infancy through adolescence,40,4140,41 2 
instead, breastfeeding was associated with increased atopic dermatitis,42-44 especially in the 3 
subgroup of children with no heredity for atopy. Consistent with that, in a systematic review 4 
and meta-analysis of 18 prospective studies, the protective effect of breastfeeding was higher 5 
in the subgroup with a positive family history of atopy.36 Contrary to that, Kull et al. showed, 6 
based on the BAMSE birth cohort, that exclusive breastfeeding for 4 months or more reduced 7 
the risk for atopic dermatitis at 4 years by about 20%, irrespective of sensitization to common 8 
food or inhalant allergens or parental allergic diseases.39  9 
Strength and limitation 10 
Our cohort is a very homogeneous, primarily healthy, cohort. The findings remain robust even 11 
if children with asthma were removed from the analysis. However, our healthy population also 12 
sets our study apart and is one of our strengths. There are limitations in terms of the 13 
generalizability of our findings. Considering Table 1 and Table S1, the sample analyzed might 14 
not fully represent the entire population of Bern. The participants tended to come from a higher 15 
socioeconomic class and the results from the included/non-included comparison analysis with 16 
loss of less-breastfed children suggest a population bias regarding the average duration of 17 
breastfeeding. The high prevalence of breastfeeding in our study makes it impossible to provide 18 
risk estimates for breastfeeding per se (breastfed children vs non-breastfed children) and makes 19 
comparisons between studies difficult. A further difficulty was quantifying the addition of 20 
formula supplementation (partial breastfeeding). This made it difficult to assess exposure dose 21 
and might have hidden a greater benefit of exclusive breastfeeding compared to partial 22 
breastfeeding. 23 
Furthermore, to avoid recall bias we prospectively asked mothers on a weekly basis, whether 24 
or not they were breastfeeding and identified the exact time point when mothers completely 25 





Although we found significant breastfeeding effects on respiratory symptoms in the first 6 2 
month of life within the same cohort,45 this study suggests that in unselected primarily healthy 3 
children with low risk for asthma, breastfeeding duration has no relevant effect on 4 
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Table 1: Characteristic of children included in the study  3 
Table 2: Association of breastfeeding with lung function and clinical data 4 
Figures 5 
 6 
Figure 1: The potential causal pathway (in concordance to Waidyatillake et al33). We 7 
hypothesized that the effect of breastfeeding on lung function is weak and might be mediated 8 
by reducing the airway inflammation and allergic sensitisation in early childhood, and also 9 
complex interaction between breastfeeding and genetic variants on respiratory infection.45,46 10 
Moreover, breastfeeding may positively influence body growth that can lead to better lung 11 
function. In addition, it is possible that reported associations between breastfeeding and lung 12 




Figure S1: Flow chart of the study population 17 
Table S1: Anthropometric data of the study participants compared to non-included 18 
children  19 
Table S2: Duration of breastfeeding stratified by exposure, N=377 20 
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Gestational age, mean (sd), weeks 377 40 (1.17) 
Gestational  length, mean (sd), cm 377 55 (2.17) 
Gestational weight, mean (sd), kg 377 22 (3.26) 
Male sex, n (%) 377 204 (54) 
Age at follow-up, mean (sd), years  345 6.03 (0.28) 
Length at follow-up, mean (sd), cm  345 117.29 (5.45) 
Weight at follow-up, mean (sd), kg  345 22.17 (3.26) 
Risk factors 
Caesarean sectio, n (%) 377 61 (16) 
Maternal smoking during pregnancy, n (%) 377 30 (8) 
Parental smoking during first year of life, n (%) 377 75 (20) 
Maternal history of allergic conditionsa, n (%) 377 123 (33) 
Maternal asthmab, n (%) 377 37 (10) 
Paternal history of allergic conditionsa, n (%) 377 132 (35) 
Paternal asthmab, n (%) 377 67 (18) 
Maternal educationc, n (%) 376  
Low  93 (25) 
Middle  132 (35) 
High  151 (40) 
Presence of older siblings, n (%)  377 200 (47) 
Exposure 
Breastfeeding   
≥1 week, n (%) 377 372 (98.7%) 
No. of week with breastfeeding, mean 
(sd) 
375 36.5 (13.9) 
Primary outcomes 
Spirometry 
FEV1, mean (sd), L 204 1.28 (0.20) 
FEV1, % predicted, mean (sd) 204 100.3 (11.3) 
FVC, mean (sd), L 82 1.4 (0.26) 
FVC, % predicted, mean (sd) 82 100.8 (12.3) 
FeNO, mean (sd) ppb 279 7.81 (6.98) 
Body plethysmography 
FRCpleth, mean (sd), L 260 1.07 (0.19) 
TLCpleth, mean (sd), L 198 2.05 (0.33) 
Reff, mean (sd), kPa*s/L 263 0.68 (0.20) 
Secondary outcomes 
Asthma, n (%) 345  18 (5) 
Ever wheezing, n (%) 345  72 (21) 
Current wheezing, n (%) 345  18 (5) 
Presence of allergic conditions, n (%) 346  100 (29) 
Rhinoconjunctivitis, n (%) 372 71 (19) 
Atopic dermatitis at 6 years, n (%) 366 38 (11) 
Positive skin prick test, n (%) 302 40 (13) 
a defined as self-reported doctor diagnosed asthma, atopic dermatitis or allergic rhinoconjunctivitis; 
b defined as self-reported doctor diagnosed asthma; c categorized into low (less than four years of 
apprenticeship), middle (four years of apprenticeship and above) and high (tertiary education). 
 
 
Table 2: Association of breastfeeding with lung function and clinical data 
 Baseline modela Adjusted modelb 
Breastfeeding (wks) N Coeff (95%CI) p-value N Coeff (95%CI) p-value 
       
Spirometry       
FEV1, ml  204 -0.46 (-1.88; 0.94) 0.513 204 -0.23(-1.65; 1.19) 0.747 
Bodyplethysmography       
FRCpleth, ml 260 -0.3 (-1.91; 1.31) 0.714 260 -0.14 (-1.75; 1.47) 0.866 
TLCpleth,ml 198 0.59 (-2.09; 3.27) 0.667 198 0.77 (-1.87; 3.41) 0.564 















       
 Univariable model Adjusted modelc 
Breastfeeding (wks) N OR (95%CI) p-value N OR (95%CI) p-value 
       
Clinical data       
Asthma 345 0.99(0.96;1.02) 0.397 345 0.99(0.97;1.03) 0.816 
Ever wheezing 345 0.99(0.97;1.01) 0.298 345 1.00(0.98;1.01) 0.634 
Current wheezing 345 0.99(0.96;1.02) 0.542 345 1.00(0.97;1.03) 0.976 
Presence of allergic 
conditions 
346 0.98(0.96;1.00) 0.018 346 0.99(0.97;1.00) 0.068 
Rhinoconjunctivitis 372 0.98(0.97;1.00) 0.071 371 0.99(0.97;1.01) 0.194 
Atopic Dermatitis 366 0.98(0.96;1.00) 0.080 365 0.99(0.96;1.01) 0.187 
Positive skin prick test 302 0.99(0.97;1.01) 0.379 302 0.99(0.97;1.02) 0.579 
Abbreviation: N, complete data; Coeff, regression coefficient; 95% CI, 95% confidence interval; OR, odds ratio. 
Effect is reported per week of breastfeeding 
a  adjusted only for anthropometric data (age, height, and sex) 
b adjusted for sex, maternal smoking during pregnancy, and parental atopy 
c  adjusted for sex, maternal smoking during pregnancy, parental atopy, and maternal education. Ever wheezing was 





Figure 1: The potential causal pathway (in concordance to Waidyatillake et al33). We hypothesized that the 
effect of breastfeeding on lung function is weak and might be mediated by reducing the airway inflammation 
and allergic sensitisation in early childhood, and also complex interaction between breastfeeding and genetic 
variants on respiratory infection.45,46 Moreover, breastfeeding may positively influence body growth that 
can lead to better lung function. In addition, it is possible that reported associations between breastfeeding 




























































































































Table S1: Anthropometric data of the study participants compared to non-included children  
 Included Non-included p-value 










Male sex, n (%) 







Length at birth, mean (sd), cm 49.6 (2.0) 48.9 (2.2) 0.998 










Caesarean section, n (%) 
Maternal smoking during pregnancy, n (%) 
Parental smoking during first year of life, n 
(%) 
















Maternal asthma, n (%) 


















Maternal education b 
low, n (%) 
middle, n (%) 
high, n (%) 
 











       
      0.020 
 
 
       
      0.526 
 
 
      
 
<0.001 

















26 (18)                
                                        
Values are mean (standard deviation) or number (percentage). a defined as self-reported, doctor-diagnosed asthma, 
rhinitis  or atopic dermatitis; b categorized into low (less than four years of apprenticeship), middle (four years of 





Table S2: Duration of breastfeeding stratified by exposure, N=377 
 N (%) Median in weeks IQR in weeks 
Study population 377   













Gestational age  












































































Parental smoking  



























1 Data were available for n=376. 2 Data were available for n=236 
in bold shown the significant difference (p-value<0.05) 
 
 
Table S3: Association of breastfeeding with lung function in non-asthmatic children 
 Adjusted modela 
Breastfeeding (wks) N Coeff (95%CI) p-value 
    
Spirometry    
FEV1, ml  195 -0.28 (-1.76; 1.20) 0.713 
Bodyplethysmography    
FRCpleth, ml 245 -0.04 (-1.68; 1.60) 0.958 
TLCpleth,ml 185 1.20 (-1.47; 3.88) 0.377 
Reff, ml 248 1.17 (-0.70; 3.04) 0.219 
 
FeNO, ppb 
 
266 
 
1.00 (0.99;1.01) 
 
0.556 
 
 
